Xiaoyan Yan

机构：Peking University, Peking University First Hospital · ORCID：0000-0001-6651-9372

发表论文 87 篇 · 总被引 1612 次 · h-index 17

代表论文

• Effect of an Herbal-Based Injection on 28-Day Mortality in Patients With Sepsis (2023 · JAMA Internal Medicine · 被引 102)
• Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer (2022 · JAMA Network Open · 被引 52)
• Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia (2022 · Journal of Hematology & Oncology · 被引 28)
• Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial (2024 · EClinicalMedicine · 被引 26)
• Efficacy and safety of single-dose suraxavir marboxil tablet in the treatment of acute uncomplicated influenza in adults: a multi-centre, randomized, double-blind, placebo-controlled phase 2 clinical trial (2025 · Clinical Microbiology and Infection · 被引 12)
• Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysis (2024 · Translational Lung Cancer Research · 被引 12)